2,6,10,14,18,22,26,30,34,38,42-Tetratetracontaundecaen-1-ol,3,7,11,15,19,23,27,31,35,39,43-undecamethyl-,(2Z,6Z,10Z,14Z,18Z,22Z,26Z,30E,34E,38E)- (26296-50-4)

Identification
Name:	2,6,10,14,18,22,26,30,34,38,42-Tetratetracontaundecaen-1-ol,3,7,11,15,19,23,27,31,35,39,43-undecamethyl-,(2Z,6Z,10Z,14Z,18Z,22Z,26Z,30E,34E,38E)-
Synonyms:	2,6,10,14,18,22,26,30,34,38,42-Tetratetracontaundecaen-1-ol,3,7,11,15,19,23,27,31,35,39,43-undecamethyl-, (Z,Z,Z,Z,Z,Z,Z,E,E,E)- (8CI);Cleomeprenol 11; Ficaprenol (C55); Ficaprenol 11; Malloprenol 11; Moraprenol 11
CAS:	26296-50-4
Molecular Formula:	C55H90 O
Molecular Structure:
Properties
Safety Data

Other Product

1/C28H41N5O15S.Na/c1-12(2)21(28(42)43)33-26(41)17(9-15-5-7-16(8-6-15)48-49(44,45)46)31-25(40)18(29-13(3)35)10-20(37)32-27-22(30-14(4)36)24(39)23(38)19(11-34)47-27;/h5-8,12,17-19,21-24,27,34,38-39H,9-11H2,1-4H3,(H,29,35)(H,30,36)(H,31,40)(H,32,37)(H,33,41
1/C51H74N2/c1-5-9-13-17-21-49(22-18-14-10-6-2)42-53(43-50(23-19-15-11-7-3)24-20-16-12-8-4)51-39-37-47(38-40-51)32-31-45-27-25-44(26-28-45)29-30-46-33-35-48(41-52)36-34-46/h25-40,49-50H,5-24,42-43H2,1-4H3/b30-29+,32-31
1/C33H42O7/c1-19-25-17-24-18-27(39-22(4)35)20(2)29(32(24,5)6)30(37)31(33(25,7)16-15-26(19)38-21(3)34)40-28(36)14-13-23-11-9-8-10-12-23/h8-14,24-27,30-31,37H,1,15-18H2,2-7H3/b14-13+/t24-,25-,26+,27+,30-,31+,33-/m1/s
6,10,14,18,22,26,30,34,38,42-Tetratetracontadecaen-1-ol,3,7,11,15,19,23,27,31,35,39,43-undecamethyl-, (6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E,38E)-
2,6,10,14,18,22,26,30-Tetratetracontaoctaen-1-ol,3,7,11,15,19,23,27,31,35,39,43-undecamethyl-,(2Z,6Z,10Z,14Z,18Z,22Z,26Z,30E,35R,39R)-
6,10,14,18,22,26,30,34,38-Dotetracontanonaen-1-ol,3,7,11,15,19,23,27,31,35,39-decamethyl-42-(1-naphthalenylamino)-,dihydrogen phosphate (ester),(6Z,10Z,14Z,18Z,22Z,26Z,30E,34E,38E)-
2,6,10,14,18,22,26,30,34,38,42,46-Octatetracontadodecaen-1-ol,3,7,11,15,19,23,27,31,35,39,43,47-dodecamethyl-, (2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E,38E,42E)-
1/C27H27N3O3S/c1-30-25(20-11-15-23(33-3)16-12-20)24(19-9-13-22(32-2)14-10-19)29-27(30)34-18-17-28-26(31)21-7-5-4-6-8-21/h4-16H,17-18H2,1-3H3,(H,28,31
(2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34Z,38E,42E,46E)-3,7,11,15,19,23,27,31,35,39,43,47,51-tridecamethyldopentaconta-2,6,10,14,18,22,26,30,34,38,42,46,50-tridecaen-1-ol
6,10,14,18,22,26,30,34,38-Tetracontanonaen-1-ol,3,7,15,19,23,27,31,35,39-nonamethyl-11-[(1-naphthalenylamino)methyl]-, dihydrogen phosphate (ester), (6Z,10E,14Z,18Z,22Z,26Z,30E,34E)-
2,6,10,14,18,22,26,30,34-Hexatriacontanonaen-1-ol,3,7,11,15,19,23,27,31,35-nonamethyl-, (2Z,6Z,10Z,14Z,18Z,22Z,26E,30E)-
1/C26H18O2/c1-17-16-23-21-9-5-3-7-19(21)11-13-25(23)28-26(17)15-14-22-20-8-4-2-6-18(20)10-12-24(22)27-26/h2-16H,1H
1/C21H26N2O4/c1-3-14-8-9-19(25)23(12-14)11-10-16-15-6-4-5-7-18(15)22-20(16)17(13-24)21(26)27-2/h4-7,12,17,22,24H,3,8-11,13H2,1-2H
2,6,10,14,18,22,26,30,34,38-Tetracontadecaen-1-ol,3,7,11,15,19,23,27,31,35,39-decamethyl-, 1-(dihydrogen phosphate),(2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34Z)-
2,6,10,14,18,22,26,30,34,38-Tetracontadecaen-1-ol,3,7,11,15,19,23,27,31,35,39-decamethyl-, dihydrogen phosphate, diammonium salt,(2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34Z)- (9CI)
2,6,10,14,18,22,26,30,34,38,42,46,50,54-Hexapentacontatetradecaen-1-ol,3,7,11,15,19,23,27,31,35,39,43,47,51,55-tetradecamethyl-,(2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34Z,38Z,42E,46E,50E)-
1/C22H28O6/c1-23-17-11-21(27-5)19(25-3)9-15(17)13-7-8-14(13)16-10-20(26-4)22(28-6)12-18(16)24-2/h9-14H,7-8H2,1-6H3/t13-,14
1/C30H52/c1-10-25(6)16-12-20-30(9,21-13-17-26(7)15-11-14-23(2)3)29-22-27(8)18-19-28(29)24(4)5/h10,17,22-23,25,28-29H,1,4,11-16,18-21H2,2-3,5-9H3/b26-17
2,6,10,14,18,22,26,30,34,38,42,46,50,54,58,62,66,70-Doheptacontaoctadecaen-1-ol,3,7,11,15,19,23,27,31,35,39,43,47,51,55,59,63,67,71-octadecamethyl-,(2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34Z,38Z,42Z,46Z,50Z,54Z,58Z,62Z,66Z,70Z)- (9CI)
2,6,10,14,18,22,26,30,34,38,42,46-Octatetracontadodecaen-1-ol,3,7,11,15,19,23,27,31,35,39,43,47-dodecamethyl-, dihydrogen phosphate,diammonium salt, (2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34Z,38Z,42Z)- (9CI)